N C Yoo
Overview
Explore the profile of N C Yoo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim H, Rha S, Cheon S, Roh J, Park Y, Yoo N
Ann Oncol
. 2009 Jan;
20(4):780-7.
PMID: 19179547
Background: Primary hepatic angiosarcoma is a very rare malignancy with a poor prognosis. While surgical resection has been validated as curative choice, most cases are diagnosed too late for resection....
2.
Chang H, Rha S, Jeung H, Im C, Ahn J, Kwon W, et al.
Ann Oncol
. 2008 Oct;
20(2):272-7.
PMID: 18836089
Background: ABCB1 is responsible for multidrug resistance, the principal mechanism by which many cancers develop resistance to chemotherapeutic drugs. There is a controversy whether ABCB1 gene polymorphisms correlate with survival...
3.
Jeung H, Moon Y, Rha S, Yoo N, Roh J, Noh S, et al.
Ann Oncol
. 2007 Nov;
19(3):520-6.
PMID: 18029971
Background: This phase III trial was to compare 5-fluorouracil (5-FU), adriamycin, and polyadenylic-polyuridylic acid (poly A:U) against 5-fluorouracil plus adriamycin (FA) for operable gastric cancer. Patients And Methods: From 1984...
4.
Jeung H, Rha S, Cho B, Yoo N, Roh J, Roh W, et al.
Br J Cancer
. 2006 Nov;
95(12):1637-41.
PMID: 17106441
This is the first phase II study of S-1 monotherapy for patients with metastatic colorectal cancer after failure of both irinotecan- and oxaliplatin-containing regimens. The initial dose of S-1 was...
5.
Shin H, Sohn J, Goo Y, Park J, Choi C, Kim E, et al.
Yonsei Med J
. 2001 Oct;
42(5):576-9.
PMID: 11675690
In this paper, a case of corneal squamous cell carcinoma is reported. Invasive squamous cell carcinoma of the cornea is a rare disorder and has not been previously described in...
6.
Ahn J, Shim K, Jeung H, Rha S, Yoo N, Kim N, et al.
Cancer Lett
. 2001 May;
167(2):215-24.
PMID: 11369143
We investigated the dose-related effect of the 5-fluorouracil (5-FU)/leucovorin regimen on survival in 139 colon cancer patients with Dukes' B2 and C2 stage disease. Chemotherapy consisted of 400 mg/m(2) of...
7.
Song J, Suh C, Park Y, Lee S, Yoo N, Lee J, et al.
Eur J Nucl Med
. 2001 May;
28(4):489-97.
PMID: 11357500
Previous animal studies have established that the intra-articular injection of holmium-166-chitosan complex (DW-166HC) causes effective necrosis of the inflamed synovium with litle leakage of radioactivity from the injected joint. Based...
8.
Ahn J, Ko W, Lee J, Shim K, Jeung H, Park J, et al.
Am J Clin Oncol
. 2001 Feb;
23(6):622-8.
PMID: 11202811
Cisplatin-based chemotherapy is being tried in the treatment of nonoperable cases of non-small-cell lung cancer (NSCLC). However, the prognosis is unfavorable and to improve survival, clinical studies using various combinations...
9.
Chang K, Kim J, Yoo N, Kim W, Park J, Choi I, et al.
Yonsei Med J
. 2000 Nov;
41(5):600-6.
PMID: 11079620
A depressed level of natural killer (NK) activity is one of the various immunologic abnormalities in human immunodeficiency virus (HIV) infection. Interleukin-15 (IL-15), an immunotherapeutic candidate in HIV infection, increases...
10.
Gong S, Rha S, Yoo N, Roh J, Yang W, Lee K, et al.
Int J Mol Med
. 2000 Aug;
6(3):301-5.
PMID: 10934293
Cancer invasion is induced by several proteolytic enzyme systems associated with the destruction of basement membrane and extracellular matrix. Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor-1 (PAI-1) have been...